Stockscreener 앱 받기
15.65
1.29%
0.20
전일 마감가:
$15.45
열려 있는:
$15.48
하루 거래량:
3.77M
Relative Volume:
1.73
시가총액:
$3.90B
수익:
$496.43M
순이익/손실:
$71.35M
주가수익비율:
54.93
EPS:
0.2849
순현금흐름:
$151.57M
1주 성능:
+23.91%
1개월 성능:
+4.47%
6개월 성능:
-12.28%
1년 성능:
+2.96%
1일 변동 폭
$15.37
$15.99
1주일 범위
$12.57
$15.99
52주 변동 폭
$11.02
$19.98
셀러브라이트 Stock (CLBT) Company Profile
Compare CLBT vs MSFT, ORCL, PLTR, FTNT, NET
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
15.65 | 3.64B | 496.43M | 71.35M | 151.57M | 0.2849 |
MSFT
Microsoft Corp
|
390.49 | 2.77T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
140.27 | 422.13B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
129.30 | 279.69B | 5.22B | 2.29B | 2.69B | 0.8876 |
FTNT
Fortinet Inc
|
156.25 | 112.55B | 7.11B | 1.95B | 2.44B | 2.5883 |
NET
Cloudflare Inc
|
242.41 | 87.06B | 2.33B | -86.74M | 291.77M | -0.2483 |
셀러브라이트 Stock (CLBT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-28 | 재확인 | Needham | Buy |
| 2024-03-13 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-07-19 | 개시 | Craig Hallum | Buy |
| 2022-08-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | 개시 | JP Morgan | Overweight |
| 2022-02-11 | 개시 | Deutsche Bank | Buy |
| 2021-12-02 | 개시 | BofA Securities | Buy |
| 2021-10-21 | 개시 | Citigroup | Buy |
모두보기
셀러브라이트 주식(CLBT)의 최신 뉴스
Form 144 CELLEBRITE DI LTD. For: 1 July - Investing.com UK
Form 144 CELLEBRITE DI LTD. For: 1 July By Investing.com - Investing.com Canada
CLBT (NASDAQ) Form 144 shows proposed option-based share sales - Stock Titan
Form 144 Cellebrite DI Ltd. For: 30 June - Investing.com UK
Form 144 Cellebrite DI Ltd. For: 30 June By Investing.com - Investing.com Canada
Cellebrite (NASDAQ: CLBT) files to sell 282,905 vested RSUs via broker - Stock Titan
Why is Cellebrite stock gaining today? By Investing.com - Investing.com Australia
Price to book forward of Cellebrite DI Ltd. – NASDAQ:CLBT - TradingView
Price to earnings forward of Cellebrite DI Ltd. – NASDAQ:CLBT - TradingView
Enterprise value to EBITDA forward of Cellebrite DI Ltd. – NASDAQ:CLBT - TradingView
Price to sales forward of Cellebrite DI Ltd. – NASDAQ:CLBT - TradingView
Cellebrite DI Ltd. Actuals & Estimates (NASDAQ:CLBT) - TradingView
CLBT Forecast — Price Target — Prediction for 2027 - TradingView
Russia Breaks Into Human Rights Activist’s Phone With Cellebrite - The Citizen Lab
AI Security Stocks In Focus As US Data Protection Pressure Builds - simplywall.st
Cellebrite DI Ltd. (CLBT) Q1 earnings and revenues top estimates - MSN
Cellebrite DI strategy in focus, Nasdaq-listed shares under analyst scrutiny - AD HOC NEWS
Cellebrite DI (CLBT) Stock Could Be 23% Undervalued After Genesis AI Launch - simplywall.st
Cellebrite (CLBT)’s Total Addressable Market Is Large, Growing, And Likely Understated, According To DA Davidson - Yahoo Finance
Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now? - Insider Monkey
10 Stocks Under $20 That Will Explode - Insider Monkey
Cellebrite DI Ltd (CLBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cellebrite DI Ltd (CLBT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cellebrite DI Ltd (CLBT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cellebrite DI Ltd (CLBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cellebrite DI Ltd (CLBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cellebrite DI Ltd (CLBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cellebrite DI Ltd (CLBT) Institutional Confidence - TradingKey
Cellebrite DI Ltd (CLBT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cellebrite DI Ltd (CLBT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Will Cellebrite’s AI‑Powered Genesis Platform Redefine Cellebrite DI's (CLBT) Narrative on Evidence Analysis? - simplywall.st
Cellebrite DI Ltd Faces Market Dynamics as Stock Volatility Surges - timothysykes.com
Cellebrite: Stronger Fundamentals Support A Buy Rating (NASDAQ:CLBT) - Seeking Alpha
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating - Moomoo
Cellebrite Genesis: AI-Powered Investigative Solutions - SecurityInformed.com
Cellebrite Genesis: AI investigative tool launch - SourceSecurity.com
[PRNewswire] Cellebrite Launches the New Age of Investigations - Yonhap News Agency
Cellebrite DI Ltd. (CLBT) Latest Stock News & Headlines - Yahoo Finance
CLBT: AI-powered tools now deliver rapid, multi-source investigative insights, transforming case workflows - TradingView
Cellebrite launches AI investigation tool Genesis By Investing.com - Investing.com
Cellebrite Di Ltd. Announces General Availability of Genesis - marketscreener.com
Cellebrite DI Ltd stock (IL0011384071): Focus on digital intelligence growth after recent earnings - Ad-hoc-news.de
Cellebrite Announces Upcoming Investor Events on June 10, 2026 - PR Newswire
Cellebrite receives FedRAMP High Authorization for cloud platform - Investing.com
[PRNewswire] Cellebrite Announces Upcoming Investor Events - Yonhap News Agency
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - The Motley Fool
TD Cowen reiterates Buy rating on Cellebrite stock at $23 target By Investing.com - Investing.com South Africa
TD Cowen reiterates Buy rating on Cellebrite stock at $23 target - Investing.com Australia
Tracking How the Cellebrite (CLBT) Investment Narrative Is Evolving Without New Analyst Targets - Yahoo Finance
CLBT News | CELLEBRITE DI LTD (NASDAQ:CLBT) - ChartMill
Cellebrite DI Ltd. Hits Day High with 11.59% Surge in Stock Price - MarketsMojo
셀러브라이트 (CLBT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.60%
2.20%
자본화:
|
볼륨(24시간):